five

A proteome dataset for TLR4 & IL1R activation & inhibition via FDA /EMA -approved drugs in chondrocytes, osteoblasts and synoviocytes

收藏
NIAID Data Ecosystem2026-03-14 收录
下载链接:
https://data.mendeley.com/datasets/v8sxysdhfb
下载链接
链接失效反馈
官方服务:
资源简介:
Mendely Data associated with: Title: A transcriptome & proteome dataset for TLR4 & IL1R activation & inhibition in chondrocytes, osteoblasts and synoviocytes Journal Title: Data in Brief Corresponding Author: Dr. Rodolfo Gomez All Authors: Eloi Franco-Trepat; María Guillán-Fresco; Ana Alonso-Pérez; Miriam López-Fagúndez; Andrés Pazos-Pérez; Antia Crespo-Golmar; Oreste Gualillo; Alberto Jorge-Mora; Susana Belén Bravo; Rodolfo Gomez DOI: PENDING The data provided is also associated as Supplementary Data to Title: Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells Journal Title: Biomedicine & Pharmacotherapy Corresponding Author: Dr. Rodolfo Gomez All Authors: Eloi Franco-Trepat; María Guillán-Fresco; Ana Alonso-Pérez; Miriam López-Fagúndez; Andrés Pazos-Pérez; Antia Crespo-Golmar; Oreste Gualillo; Alberto Jorge-Mora; Susana Belén Bravo; Rodolfo Gomez DOI: doi.org/10.1016/j.biopha.2022.113671 Data Description Table 1 Merged dataset of approved drugs by the Federal Drugs Agency (FDA) & European Medicine Agency (EMA). Synonyms, formulations, and doses were included as individual entries. Table 2 Merged dataset of approved active compounds by the Federal Drugs Agency (FDA) & European Medicine Agency (EMA). Synonyms, formulations, and doses were included as individual entries. Table 3 List of all primers used in the manuscript including sequence, melting temperature and RefSeq. All primers were purchased as “KiCqStart® SYBR® Green Primers” ref. KSPQ12012 (Merck; USA). Table 4 Cellular proteome & secretome qualitative DDA data (n3) obtained by MALDI-TOFF of primary human OA chondrocytes (Control, TLR4 agonist LPS [100ng/ml] and IL1R agonist IL1β [0.1ng/ml]). Table 5 Cellular proteome quantitative SWATH data (n=3) obtained by MALDI-TOFF of primary human OA chondrocytes (Control, TLR4 agonist LPS [100ng/ml] and IL1R agonist IL1β [0.1ng/ml]).
创建时间:
2022-09-15
二维码
社区交流群
二维码
科研交流群
商业服务